Clarametyx Biosciences | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Email & Communication
Keywords & Focus Areas
Clarametyx Biosciences
Overview
Clarametyx Biosciences is a clinical-stage biotechnology company located in Columbus, Ohio. The company specializes in developing innovative immune-enabling therapies and vaccines aimed at treating and preventing bacterial biofilm-mediated diseases, particularly serious respiratory infections such as pneumonia and cystic fibrosis-associated pulmonary infections. Their approach focuses on targeting bacterial biofilms, which are a major contributor to persistent infections and antimicrobial resistance.
The company's technology platform features an anti-biofilm vaccine candidate designed to prevent bacterial biofilm formation and an immune-enabling antibody therapy in development for chronic respiratory infections. Clarametyx collaborates with healthcare providers and pharmaceutical partners to advance anti-infective therapies, with the goal of reducing reliance on antibiotics and combating biofilm-mediated infections across various body systems.
Basic Information
| Industry | research |
|---|---|
| Founded | 2020 |
| Revenue | 1.2M |
| Headquarters | 1275 Kinnear Road, Columbus, Ohio 43212, United States |
Contact Details
- Phone: +1 614-686-2689
- Website: clarametyx.com
- LinkedIn: linkedin.com/company/clarametyx-biosciences
Key Focus Areas & Initiatives
- Infectious disease research
- Biotechnology innovation
- Bacterial biofilms
- Antibiotic resistance mitigation
- Antibiotics and sensitization
- Biotechnology research
- Antimicrobial resistance mitigation
- Pharmaceuticals
- Monoclonal antibody therapies
- Biofilm structural disruption and targeting
- Biofilm collapse technology
- Medical research
- DNABII proteins
- Biofilm vaccines and vaccine development
- Immune-enabling biologics
- Biofilm vaccine platform and prevention
- Anti-biofilm therapies
- Biofilm matrix targeting and disruption
- Targeted biologic therapies
- Bacterial biofilm-associated infections
- Immune response enhancement
- Antimicrobial resistance
- Chronic respiratory infections
- Clinical-stage biotech development
- B2B services
- Research and development in the physical, engineering, and life sciences
- Medical initiatives
Technologies Used
- Android
- Apache
- Circle
- Domo
- GoDaddy Hosting
- Google Analytics
- Google Font API
- Google Tag Manager
- Highspot
- IoT
- Microsoft Office 365
- Mobile Friendly
- Outlook
- Remote
- Sisense
- WordPress.org
- Zendesk
Community
